A Radiology study finds one in five patients arrive for imaging exams with no information, and half go looking for it on their own.
Depression2Extinction (d2e) Welcomes ElliptiGo, Inc. as a Corporate Partner
Mental health non-profit d2e partners with ElliptiGO, maker of the first elliptical bicycle, to promote injury-free movement.
24/7 Kid Doc Announces Telemedicine Pilot Program with FL Day Care Centers
24/7 Kid Doc pilots its Connect-a-Doc telemedicine service at two Jacksonville day care centers for $9.95 per student per month.
Beasley Allen Files Opioid Lawsuit on Behalf of the State of Alabama
Beasley Allen joins Alabama Attorney General Steve Marshall in a state lawsuit against opioid maker Purdue Pharma over its marketing of painkillers.
Are Cell Phones Linked to Brain Cancer? National Toxicology Program Releases Results of Multi-Year Study
Draft NTP studies link high radiofrequency exposure to heart tumors in male rats, while brain tumor findings stay unclear.
Initiator Pharma Receives an Intention to Grant Notice in Europe for Its Pipeline Product Candidate IPDP2015 for Treatment of Depression
Initiator Pharma received a European Intention to Grant notice for IPDP2015, its depression candidate, with protection planned until 2029.
Risk-Based Auditing Software Helps Keep Healthcare Spending Under Control
Risk-based auditing software helps healthcare organizations focus reviews on high-risk claims and keep spending under control.
Patient Writes Highly Personal Account of His Hip Replacement Experience to Help Others Considering the Surgery
HSS patient John Harbour wrote Diary of Hippie, a first-hand journal of his total hip replacement, to guide others facing the surgery.
HCell Granted Orphan Drug Designation from the U.S. FDA for HC017AA Alopecia Areata in the Pediatric Population
Austin biotech HCell won FDA Orphan Drug Designation for HC017AA, an injection being developed for children with alopecia areata.
Andrew E. Sloan, MD, Recognized for Achievements in Neurosurgery
Marquis Who’s Who recognizes Cleveland neurosurgeon Andrew E. Sloan, MD, a pioneer of brain tumor immunotherapy at Case Western Reserve University.